. 2023 Oct 30;19(2):224–232. doi: 10.2215/CJN.0000000000000342

Table 3.

Results comparing the overnight icodextrin dwell, the continuous ambulatory peritoneal dialysis dwell, and the three different glucose doses of the steady concentration peritoneal dialysis treatments

Treatment	Treatment Time, h	Ultrafiltration Volume, mL/Treatment	Ultrafiltration Rate, mL/h	Glucose Absorption Rate, g/h	Glucose Ultrafiltration Efficiency, mL Ultrafiltration/g Glucose Absorbed	Sodium Removal, mmol/Treatment	Albumin Loss, g/Treatment
Overnight icodextrin dwell (n=8)	12.1±1.0^a	617±191^a	51±15	NA	NA	92±27^a	3.0±1.2^a
CAPD dwell with 2.5% dextrose (n=8)	4.1±0.1^b	162±242^b	40±60	7.8±1.1	5.9±7.8	21±33^b	1.1±0.4^b
Carry Life UF 11 g/h (n=8)	5.2±0.3^a^,^b	646±256^a	124±49^c^,^d	8.2±2.0	17.0±10.6^d	86±27^a	1.4±0.6^b
Carry Life UF 14 g/h (n=8)	5.1±0.3^a^,^b	739±312^a	146±63^a^,^b	10.4±1.0^a	14.5±7.7^d	92±33^a	1.3±0.5^b
Carry Life UF 20 g/h (n=8)	5.2±0.2^a^,^b	863±380^a	168±78^a^,^b	14.0±1.5^a	12.4±6.8^e	110±37^a	1.2±0.4^b

Data are presented as mean±SD. Note that the fill volume was 2 L with the icodextrin dwell and the continuous ambulatory peritoneal dialysis dwell, whereas the fill volume was 1.5 L with the Carry Life UF treatments. NA, not applicable; CAPD, continuous ambulatory peritoneal dialysis.

Significant differences are denoted.

P < 0.001 versus the continuous ambulatory peritoneal dialysis dwell.

P < 0.001 versus the icodextrin dwell.

P < 0.01 versus the icodextrin dwell.

P < 0.01 versus the continuous ambulatory peritoneal dialysis dwell.

P < 0.05 versus the continuous ambulatory peritoneal dialysis dwell.